Journal of Bioequivalence & Bioavailability

Pavan Todkar

Publications

• Research Article
  An Overview on Bioequivalence: Regulatory Consideration for Generic Drug Products
  Author(s): Asif M. Tamboli, Pavan Todkar, Priti Zope and F.J. SayyadAsif M. Tamboli, Pavan Todkar, Priti Zope and F.J. Sayyad
  
  Generic pharmaceutical products need to con fi rm to the same standards of quality, ef fi cacy and safety as required of the originator’s (innovator) product. Speci fi cally, the Generic product should be therapeutically equivalent and interchangeable with the reference product. Testing the bioequivalence between a test product pharmaceutically equivalent or a pharmaceutical alternative and a suitable reference product in a pharmacokinetic study with a limited number of subjects is one way of demonstrating therapeutic equivalence. Generic drug applications are termed “abbreviated” because they are generally not required to include preclinical and clinical data to establish safety and effectiveness. This paper provides the information about important aspect involved in bioequivalence and Regulatory requirement for Bioequivalence study. .. View More»
  DOI: 10.4172/jbb.1000037

  Abstract PDF